General Archive
-
News releasesTwo major UK decisions announced on use of Alzheimer’s drug, lecanemab
Today, two major decisions have been made on lecanemab (Leqembi®) – the Alzheimer’s drug that we helped humanise, which slows the…
-
Articles & blogsLifeArc contributes to organic chemistry breakthrough
The findings reveal that seemingly impossible chemical reactions can be driven through a phenomenon called quantum tunnelling.
-
Articles & blogsStudy reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
-
LifeArc collaboration helps to advance a potential new cancer drug towards the clinic
Making our unique ULK inhibitors available as tools for the academic community has helped to reignite interest in blocking autophagy…
-
Exploring new approaches to drug discovery
LifeArc’s scientists have been working on a fresh approach to drug discovery, using a parallel high-throughput application to significantly improve…
-
Rising to the challenge of COVID-19
While the development of COVID-19 vaccines has garnered much attention, scientists have also been looking at repurposed medicines as an…
-
How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response
In 2020 the UK Government, supported by UK Research and Innovation and the National Institute for Health and Research, launched…
-
LifeArc scientists play pivotal role in the search for a COVID-19 antibody therapy
While much attention in the race for treatments for Covid-19 has been on the development of new vaccines, scientists have…
-
Virtual reality technology for small molecular drug discovery
A project by an industrial placement student led to Virtual Reality becoming a powerful tool for drug discovery Technology has…
-
Life, re-engineered: new milestone in the emerging field of synthetic genomics
When MRC researchers achieved a new milestone in the emerging field of synthetic genomics, LifeArc set this early-stage technology on…
-
Modelling the human brain
Candidate drugs to treat the central nervous system could be screened with three-dimensional brain tissue grown in the laboratory. We…
-
Keytruda: a new generation of cancer treatment
In 2007, LifeArc entered a collaboration with Organon – ultimately acquired by Merck – to translate innovative drug targets into…